收藏切换
Preparation of VEGFA/B Antagonistic Supramolecular Peptides and Their Application in the Treatment of Melanoma in Mice
收藏切换
Qian ZHANG1, 2, Wenqi LIU2, Yuelin FANG1, 2, Xinxin ZHANG1, 2, 3, *
Chinese Journal of Pharmaceuticals | 2026, 57(5) : 546 - 556
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2026, 57(5): 546-556
• Paper •
Preparation of VEGFA/B Antagonistic Supramolecular Peptides and Their Application in the Treatment of Melanoma in Mice
Full
Qian ZHANG1, 2, Wenqi LIU2, Yuelin FANG1, 2, Xinxin ZHANG1, 2, 3, *
Affiliations
  • 1.Tianjin University of Traditional Chinese Medicine, Tianjin 301600
  • 2.Shandong Lab. of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264100
  • 3.Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203
Published: 2026-05-10 doi: 10.16522/j.cnki.cjph.2026.05.007
Outline
收藏切换

Peptide drugs occupy a unique position in the field of tumor therapy due to their high specificity and potent activity. However, their clinical translation and application are often restricted by poor stability and low cellular uptake efficiency. To address this, this study employed the vascular endothelial growth factor A/B antagonistic peptide VGB3 as the model drug, and screened amphiphilic molecules bearing ion-pair structures in combination with salt ions to drive the preparation of VGB3 supramolecular peptide(V-SMP). The average particle size of V-SMP was approximately 150 nm, and it appeared as monodisperse regular spherical particles under a transmission electron microscope and exhibited good stability. Cell experiment results showed that V-SMP increased the uptake efficiency of VGB3 in mouse melanoma cells(B16F10 cells) by 1.49-fold and effectively inhibited tumor cell proliferation. In a subcutaneous syngeneic model of B16F10 melanoma, V-SMP significantly inhibited tumor growth, achieving antitumor efficacy nearly twice that of the free peptide. In summary, this supramolecular peptide formulation improves both the stability and therapeutic activity of peptide drugs, providing a valuable reference for tumor therapy and peptide drug development.

peptide drug  /  vascular endothelial growth factor A/B antagonist peptide  /  supramolecular peptide  /  antitumor  /  melanoma
张倩, 刘文琦, 方跃霖, 张馨欣. VEGFA/B拮抗超分子肽的制备及其在小鼠黑色素瘤治疗中的应用. 中国医药工业杂志, 2026 , 57 (5) : 546 -556 . DOI: 10.16522/j.cnki.cjph.2026.05.007
Qian ZHANG, Wenqi LIU, Yuelin FANG, Xinxin ZHANG. Preparation of VEGFA/B Antagonistic Supramolecular Peptides and Their Application in the Treatment of Melanoma in Mice[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (5) : 546 -556 . DOI: 10.16522/j.cnki.cjph.2026.05.007
Year 2026 volume 57 Issue 5
128
35
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.05.007
  • Receive Date:2026-01-07
  • Online Date:2026-11-05
  • Published:2026-05-10
Article Data
Affiliations
History
  • Received:2026-01-07
Funding
Affiliations
    1.Tianjin University of Traditional Chinese Medicine, Tianjin 301600
    2.Shandong Lab. of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264100
    3.Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.05.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT